Conservative treatment of an early aortic graft infection due to Acinetobacter baumanii.
Acute infection of an aortic graft is a devastating complication. While resection of the infected prosthesis and extra-anatomic bypass is the established treatment, this carries a high mortality. We describe a case of early aortic graft infection with the unusual organism Acinetobacter baumanii, which was eradicated by a combination of surgical drainage and antibiotics, allowing preservation of the graft. The patient remains well 30 months later.
Pencavel
Timothy D
TD
Department of Vascular Surgery, Whipps Cross University Hospital, London, UK.
Singh-Ranger
Gurpreet
G
Crinnion
James N
JN
D040981:Acinetobacter baumannii / Q000302:isolation & purification; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017544:Aortic Aneurysm, Abdominal / Q000601:surgery; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation; D003131:Combined Modality Therapy; D003646:Debridement; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery*; D012293:Rifampin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D012293:Rifampin; D010878:Piperacillin